4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Aquatic Specific Physiotherapy on Incomplete Spinal Cord Injuries (FALMI)

Aquatic Specific Physiotherapy on Incomplete Spinal Cord Injuries (FALMI)

Study Description
Brief Summary:

Purpose of the study: To analyse the effectiveness of aquatic physiotherapy on spinal cord injuries (LMi) in the improvement of balance and gait, in the inflammatory profile, and the impact on the quality of life.

Main objective: To analyse if there are differences in the recovery of the balance, in incomplete subacute spinal cord injuries, with lesion level T1-L5 and ASIA (American Spinal Injury Association) C and D .

Secondary objectives:

  1. functional gait
  2. To evaluate if the time from the injury to the start of the aquatic therapy influences the results on balance and functional gait.
  3. To study the effect of aquatic therapy on serum markers of systemic inflammation.
  4. Quality of life related to health. Design: Crossed, controlled and randomized clinical trial, with blind evaluation of the response variables.

Scope of the study: National Hospital of Paraplegics. Toledo (Spain). Population: Subjects with incomplete spinal cord injury ASIA C and D. n = 50 (25 in each arm randomly).

Intervention:

6 weeks of specific Aquatic Physiotherapy (3 times a week). Group 1 will perform aquatic physiotherapy at the time of entering the study, and group 2 will perform it 6 weeks later.

Outcomes: Static and dynamic balance (Berg test and Time Up and Go). Speed of the gait (test of 10 m.). Gait resistance (6 min. Test). Functional capacity of the gait (WISCI II). Biomechanical analysis (sensorial-dynamic, rhythmic and directional control, and gait test) by posturography. Questionnaires EuroQol-5Dimensions-5Level (EQ-5D-5L) and the Spanish Version of the Quality of Life Index (SV-QLI) in spinal cord injury (SCI).

Biomarkers of inflammation: 20 cytokines. Analysis of results: The main outcome measure will be the percentage of patients who have improved. Considering improvement when the difference between the groups is, at least, a 10% of their score in the Berg test between V0 and V1 (with their corresponding 95% confidence intervals). It will be adjusted for confounding and interaction factors with a multivariate analysis using logistic regression. All analyses will be performed according to the intention to treat principle.


Condition or disease Intervention/treatment Phase
Spinal Cord Injuries Procedure: aquatic physiotherapy Not Applicable

Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Randomized Controlled Trial to Assess the Effectiveness of Aquatic Specific Physiotherapy in the Improvement of Balance and Gait.
Actual Study Start Date : April 1, 2019
Estimated Primary Completion Date : February 1, 2021
Estimated Study Completion Date : April 30, 2021
Arms and Interventions
Arm Intervention/treatment
Experimental: Early Aquatic Therapy (EAT)
Aquatic physiotherapy treatment at time 1 (week 1)
Procedure: aquatic physiotherapy
specific aquatic physiotherapy 3 times a week, for 6 weeks, including feet balance exercises (Rating of Perceived Effort (RPE)), slow walking in all directions, walking with obstacles, Ai Chi, exercises of muscular strength. Each session duration is of 40 minutes.
Other Name: hydrotherapy

Late Aquatic Therapy (LAT)
Control for Group 1 for the 5 first weeks of Group 1 treatment. Aquatic physiotherapy treatment at time 2 (week 6).
Procedure: aquatic physiotherapy
specific aquatic physiotherapy 3 times a week, for 6 weeks, including feet balance exercises (Rating of Perceived Effort (RPE)), slow walking in all directions, walking with obstacles, Ai Chi, exercises of muscular strength. Each session duration is of 40 minutes.
Other Name: hydrotherapy

Outcome Measures
Primary Outcome Measures :
  1. balance [ Time Frame: 12 weeks ]
    Berg test

  2. Speed of the gait [ Time Frame: 12 weeks ]
    test of 10 m

  3. Gait resistance [ Time Frame: 12 weeks ]
    6 Minutes Walk Test

  4. Functional capacity of the gait [ Time Frame: 12 weeks ]
    Walking Index for spinal cord injury (WISCI II)


Secondary Outcome Measures :
  1. General quality of life related to Health [ Time Frame: 12 weeks ]
    Measures through the Questionnaire EuroQol-5D-5L. The questionnaire comprises 5 dimensions: mobility, self care, usual activities, pain discomfort, anxiety/depression. Each dimension is scored in 5 levels, 1-5 (level 1-no problem, level 5,-extreme problems). Based on the answers, a index value from 0 to 1 is calculated (0-the worst quality of life, 1-the best quality of life).

  2. Specific quality of life related to health in spinal cord injury [ Time Frame: 12 weeks ]
    Measured through the questionnaire "Spanish version of the Quality of Life Index in spinal cord injury (SV-QLI / SCI)". The questionnaire evaluates 37 items, in a scale from 1 (less satisfied) to 6 (most satisfied). There are 5 scores of 0-30 (0=less satisfied, 30=most satisfied) which are calculated using the subscales: 1-Total Quality of Life score. 2-Health and Functioning Subscale. 3-Social and Economic Subscale. 4-Psychological /Spiritual Subscale. 5-Family Subscale. The final score is an average of the subscale's scores, being between 0 (0=less satisfied) and 30 (30=most satisfied).

  3. Inflammatory cytokines analysis [ Time Frame: 12 weeks ]
    Quantification of the cytokine concentration, in pg/mL, will be carried out by Luminex xMAP Bead-based multiplex Assay (Labclinics). Cytokine's panel includes the cytokines E-selectin, P-selectin, IL-1α, IL-1β, IL-10, MCP-1 (CCL2),GM-CSF, IL12p70, MIP-1α (CCL3), MIP-1β (CCL4), ICAM-1, IL-4, IL-13, IFN-α, IFN-γ, IL-6, IL-17A,(CTLA8), IL-8 (CXCL8), IP-10 (CXCL10) and TNF-α.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects with incomplete spinal cord injury T1-L5 (ASIA C y D).
  • Traumatic and not traumatic injuries, with injury date of less than 8 months.
  • Able to maintain assisted standing up
  • Subjects signing the informed consent form

Exclusion Criteria:

  • Subjects with progressive injuries.
  • heart or lung disease
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Inés Martínez-Galán, MD +34 925268800 ext 5837 ines.martinez@uclm.es

Locations
Layout table for location information
Spain
Hospital Nacional de Parapléjicos Recruiting
Toledo, Spain, 45071
Contact: María Angeles Alcaráz Rousselet, Physician    +34 925 247700    maalcaraz@sescam.jccm.es   
Sponsors and Collaborators
University of Castilla-La Mancha
Investigators
Layout table for investigator information
Principal Investigator: Inés Martínez-Galán, MD University of Castilla-La Mancha
Tracking Information
First Submitted Date  ICMJE May 14, 2019
First Posted Date  ICMJE May 23, 2019
Last Update Posted Date May 30, 2019
Actual Study Start Date  ICMJE April 1, 2019
Estimated Primary Completion Date February 1, 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: May 22, 2019)
  • balance [ Time Frame: 12 weeks ]
    Berg test
  • Speed of the gait [ Time Frame: 12 weeks ]
    test of 10 m
  • Gait resistance [ Time Frame: 12 weeks ]
    6 Minutes Walk Test
  • Functional capacity of the gait [ Time Frame: 12 weeks ]
    Walking Index for spinal cord injury (WISCI II)
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: May 28, 2019)
  • General quality of life related to Health [ Time Frame: 12 weeks ]
    Measures through the Questionnaire EuroQol-5D-5L. The questionnaire comprises 5 dimensions: mobility, self care, usual activities, pain discomfort, anxiety/depression. Each dimension is scored in 5 levels, 1-5 (level 1-no problem, level 5,-extreme problems). Based on the answers, a index value from 0 to 1 is calculated (0-the worst quality of life, 1-the best quality of life).
  • Specific quality of life related to health in spinal cord injury [ Time Frame: 12 weeks ]
    Measured through the questionnaire "Spanish version of the Quality of Life Index in spinal cord injury (SV-QLI / SCI)". The questionnaire evaluates 37 items, in a scale from 1 (less satisfied) to 6 (most satisfied). There are 5 scores of 0-30 (0=less satisfied, 30=most satisfied) which are calculated using the subscales: 1-Total Quality of Life score. 2-Health and Functioning Subscale. 3-Social and Economic Subscale. 4-Psychological /Spiritual Subscale. 5-Family Subscale. The final score is an average of the subscale's scores, being between 0 (0=less satisfied) and 30 (30=most satisfied).
  • Inflammatory cytokines analysis [ Time Frame: 12 weeks ]
    Quantification of the cytokine concentration, in pg/mL, will be carried out by Luminex xMAP Bead-based multiplex Assay (Labclinics). Cytokine's panel includes the cytokines E-selectin, P-selectin, IL-1α, IL-1β, IL-10, MCP-1 (CCL2),GM-CSF, IL12p70, MIP-1α (CCL3), MIP-1β (CCL4), ICAM-1, IL-4, IL-13, IFN-α, IFN-γ, IL-6, IL-17A,(CTLA8), IL-8 (CXCL8), IP-10 (CXCL10) and TNF-α.
Original Secondary Outcome Measures  ICMJE
 (submitted: May 22, 2019)
  • General quality of life related to Health [ Time Frame: 12 weeks ]
    Questionnaires EuroQol-5D-5L
  • Specific quality of life related to Health [ Time Frame: 12 weeks ]
    Spanish version of the Quality of Life Index in spinal cord injury (SV-QLI / SCI)
  • Biomarkers of inflammation [ Time Frame: 12 weeks ]
    Cytokines analysis. E-selectin, P-selectin, IL-1α, IL-1β, IL-10, MCP-1 (CCL2),GM-CSF, IL12p70, MIP-1α (CCL3), MIP-1β (CCL4), ICAM-1, IL-4, IL-13, IFN-α, IFN-γ, IL-6, IL-17A,(CTLA8), IL-8 (CXCL8), IP-10 (CXCL10) y TNF-α.
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Aquatic Specific Physiotherapy on Incomplete Spinal Cord Injuries
Official Title  ICMJE Randomized Controlled Trial to Assess the Effectiveness of Aquatic Specific Physiotherapy in the Improvement of Balance and Gait.
Brief Summary

Purpose of the study: To analyse the effectiveness of aquatic physiotherapy on spinal cord injuries (LMi) in the improvement of balance and gait, in the inflammatory profile, and the impact on the quality of life.

Main objective: To analyse if there are differences in the recovery of the balance, in incomplete subacute spinal cord injuries, with lesion level T1-L5 and ASIA (American Spinal Injury Association) C and D .

Secondary objectives:

  1. functional gait
  2. To evaluate if the time from the injury to the start of the aquatic therapy influences the results on balance and functional gait.
  3. To study the effect of aquatic therapy on serum markers of systemic inflammation.
  4. Quality of life related to health. Design: Crossed, controlled and randomized clinical trial, with blind evaluation of the response variables.

Scope of the study: National Hospital of Paraplegics. Toledo (Spain). Population: Subjects with incomplete spinal cord injury ASIA C and D. n = 50 (25 in each arm randomly).

Intervention:

6 weeks of specific Aquatic Physiotherapy (3 times a week). Group 1 will perform aquatic physiotherapy at the time of entering the study, and group 2 will perform it 6 weeks later.

Outcomes: Static and dynamic balance (Berg test and Time Up and Go). Speed of the gait (test of 10 m.). Gait resistance (6 min. Test). Functional capacity of the gait (WISCI II). Biomechanical analysis (sensorial-dynamic, rhythmic and directional control, and gait test) by posturography. Questionnaires EuroQol-5Dimensions-5Level (EQ-5D-5L) and the Spanish Version of the Quality of Life Index (SV-QLI) in spinal cord injury (SCI).

Biomarkers of inflammation: 20 cytokines. Analysis of results: The main outcome measure will be the percentage of patients who have improved. Considering improvement when the difference between the groups is, at least, a 10% of their score in the Berg test between V0 and V1 (with their corresponding 95% confidence intervals). It will be adjusted for confounding and interaction factors with a multivariate analysis using logistic regression. All analyses will be performed according to the intention to treat principle.

Detailed Description Not Provided
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Condition  ICMJE Spinal Cord Injuries
Intervention  ICMJE Procedure: aquatic physiotherapy
specific aquatic physiotherapy 3 times a week, for 6 weeks, including feet balance exercises (Rating of Perceived Effort (RPE)), slow walking in all directions, walking with obstacles, Ai Chi, exercises of muscular strength. Each session duration is of 40 minutes.
Other Name: hydrotherapy
Study Arms  ICMJE
  • Experimental: Early Aquatic Therapy (EAT)
    Aquatic physiotherapy treatment at time 1 (week 1)
    Intervention: Procedure: aquatic physiotherapy
  • Late Aquatic Therapy (LAT)
    Control for Group 1 for the 5 first weeks of Group 1 treatment. Aquatic physiotherapy treatment at time 2 (week 6).
    Intervention: Procedure: aquatic physiotherapy
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Unknown status
Estimated Enrollment  ICMJE
 (submitted: May 22, 2019)
50
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE April 30, 2021
Estimated Primary Completion Date February 1, 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Subjects with incomplete spinal cord injury T1-L5 (ASIA C y D).
  • Traumatic and not traumatic injuries, with injury date of less than 8 months.
  • Able to maintain assisted standing up
  • Subjects signing the informed consent form

Exclusion Criteria:

  • Subjects with progressive injuries.
  • heart or lung disease
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 70 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Spain
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03962218
Other Study ID Numbers  ICMJE ECA-FALMI-19
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE Not Provided
Responsible Party University of Castilla-La Mancha
Study Sponsor  ICMJE University of Castilla-La Mancha
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Inés Martínez-Galán, MD University of Castilla-La Mancha
PRS Account University of Castilla-La Mancha
Verification Date May 2019

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

治疗医院